Towards the molecular characterization of disease: comparison of molecular and histological analysis of esophageal epithelia
- PMID: 17623264
- DOI: 10.1007/s11605-007-0208-x
Towards the molecular characterization of disease: comparison of molecular and histological analysis of esophageal epithelia
Abstract
Reliable quantification of gene expression offers the possibility of more accurate and prognostically relevant characterization of tissues than potentially subjective interpretations of histopathologists. We measured the expression of 18 selected genes and compared them to histological features in a spectrum of esophageal disease to evaluate the feasibility of molecular characterization of normal and pathologic esophageal epithelia. Esophageal tissue biopsies from 82 patients with foregut symptoms were laser capture microdissected, and the expression levels of 18 selected genes were measured by quantitative real-time polymerase chain reaction. Linear discriminant analysis, which uses combinations of genes to distinguish between histological groups, was performed to compare gene expression and the following five histological groups: (1) normal squamous epithelium (n = 35), (2) reflux esophagitis (n = 13), (3) non-dysplastic Barrett's (n = 33), (4) dysplastic Barrett's (n = 16), (5) adenocarcinoma (n = 31). A panel of seven genes had 90-94% predictive power to distinguish non-dysplastic and dysplastic Barrett's esophagus. Clustering analysis revealed structure in gene expression values even in the absence of histology. Expression levels in 17 genes differed significantly across histological groups. Classification based on gene expression agreed with histopathological assessment in the following percentage of cases: normal squamous epithelium = 53%, reflux esophagitis = 31%, non-dysplastic Barrett's = 76%, dysplastic Barrett's = 40%, and adenocarcinoma = 59%. Interestingly, predictive power improved markedly when inflammatory and dysplastic tissues were removed (77-94%). Gene expression classification agrees well with histopathological examination. When differences occur, it is unclear whether this effect is due to intraobserver variability in pathological diagnosis or to a genuine difference between gene expression and histopathology.
Similar articles
-
The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2113-7. doi: 10.1158/1055-9965.EPI-05-0014. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16172218
-
A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.Oncogene. 2004 Jun 10;23(27):4780-8. doi: 10.1038/sj.onc.1207663. Oncogene. 2004. PMID: 15107828
-
Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.Am J Gastroenterol. 2005 Jun;100(6):1257-64. doi: 10.1111/j.1572-0241.2005.41338.x. Am J Gastroenterol. 2005. PMID: 15929754
-
Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.Gastroenterol Clin North Am. 2002 Jun;31(2):461-79, ix. doi: 10.1016/s0889-8553(02)00013-4. Gastroenterol Clin North Am. 2002. PMID: 12134613 Review.
-
Barrett's esophagus.Surg Gynecol Obstet. 1983 Apr;156(4):521-38. Surg Gynecol Obstet. 1983. PMID: 6340227 Review.
Cited by
-
The columnar-lined mucosa at the gastroesophageal junction in non-human primates.Int J Clin Exp Pathol. 2009;2(5):481-8. Epub 2008 Jan 20. Int J Clin Exp Pathol. 2009. PMID: 19294007 Free PMC article.
-
Accuracy of identification of tissue types in endoscopic esophageal mucosal biopsies used for molecular biology studies.Clin Exp Gastroenterol. 2009;2:1-7. Epub 2009 Feb 9. Clin Exp Gastroenterol. 2009. PMID: 21694820 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical